Wellington Biomedical Innovation Master Investors (Cayman) I L.P.'s Net Worth
Estimate Recalculated May 19, 2026 03:51AM EST
Who is Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. has an estimated net worth of $242 Million. This is based on reported shares across multiple companies, which include PMV Pharmaceuticals, Inc., Dyne Therapeutics, Inc., Generation Bio Co., Verve Therapeutics, Inc., Nurix Therapeutics, Inc., Edgewise Therapeutics, Inc., Nuvalent, Inc., Forma Therapeutics Holdings, Inc.,, Kymera Therapeutics, Inc., Aligos Therapeutics, Inc., Black Diamond Therapeutics, Inc., Olema Pharmaceuticals, Inc., Acrivon Therapeutics, Inc., Boundless Bio, Inc., and Artiva Biotherapeutics, Inc..
SEC CIK
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.'s CIK is 0001787092
Past Insider Trading and Trends
2020 was Wellington Biomedical Innovation Master Investors (Cayman) I L.P.'s most active year for acquiring shares with 13 total transactions. Wellington Biomedical Innovation Master Investors (Cayman) I L.P.'s most active month to acquire stocks was the month of May. 2020 was Wellington Biomedical Innovation Master Investors (Cayman) I L.P.'s most active year for disposing of shares, totalling 11 transactions. Wellington Biomedical Innovation Master Investors (Cayman) I L.P.'s most active month to dispose stocks was the month of May. 2020 saw Wellington Biomedical Innovation Master Investors (Cayman) I L.P. paying a total of $40,900,000.00 for 12,677,817 shares, this is the most they've acquired in one year. In 2021 Wellington Biomedical Innovation Master Investors (Cayman) I L.P. cashed out on 28,620,942 shares for a total of $0.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
